Literature DB >> 29033478

Bayesian variable selection for a semi-competing risks model with three hazard functions.

Andrew G Chapple1, Marina Vannucci1,2, Peter F Thall2, Steven Lin3.   

Abstract

A variable selection procedure is developed for a semi-competing risks regression model with three hazard functions that uses spike-and-slab priors and stochastic search variable selection algorithms for posterior inference. A rule is devised for choosing the threshold on the marginal posterior probability of variable inclusion based on the Deviance Information Criterion (DIC) that is examined in a simulation study. The method is applied to data from esophageal cancer patients from the MD Anderson Cancer Center, Houston, TX, where the most important covariates are selected in each of the hazards of effusion, death before effusion, and death after effusion. The DIC procedure that is proposed leads to similar selected models regardless of the choices of some of the hyperparameters. The application results show that patients with intensity-modulated radiation therapy have significantly reduced risks of pericardial effusion, pleural effusion, and death before either effusion type.

Entities:  

Keywords:  Metropolis-Hastings; Semi-Competing Risks; Variable Selection

Year:  2017        PMID: 29033478      PMCID: PMC5637455          DOI: 10.1016/j.csda.2017.03.002

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  12 in total

1.  Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.

Authors:  Steven H Lin; Ning Zhang; Joy Godby; Jingya Wang; Gary D Marsh; Zhongxing Liao; Ritsuko Komaki; Linus Ho; Wayne L Hofstetter; Stephen G Swisher; Reza J Mehran; Thomas A Buchholz; Linda S Elting; Sharon H Giordano
Journal:  Cancer       Date:  2015-12-30       Impact factor: 6.860

2.  Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.

Authors:  Xiong Wei; H Helen Liu; Susan L Tucker; Shulian Wang; Radhe Mohan; James D Cox; Ritsuko Komaki; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-11       Impact factor: 7.038

3.  Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

Authors:  Anurag Chandra; Thomas M Guerrero; H Helen Liu; Susan L Tucker; Zhongxing Liao; Xiaochun Wang; Hasan Murshed; Mark D Bonnen; Amit K Garg; Craig W Stevens; Joe Y Chang; Melinda D Jeter; Radhe Mohan; James D Cox; Ritsuko Komaki
Journal:  Radiother Oncol       Date:  2005-11-17       Impact factor: 6.280

4.  Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis.

Authors:  Kyu Ha Lee; Sebastien Haneuse; Deborah Schrag; Francesca Dominici
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2015-02-01       Impact factor: 1.864

5.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

7.  Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.

Authors:  Liru He; Andrew Chapple; Zhongxing Liao; Ritsuko Komaki; Peter F Thall; Steven H Lin
Journal:  Radiother Oncol       Date:  2016-08-22       Impact factor: 6.280

8.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Satoshi Ishikura; Keiji Nihei; Atsushi Ohtsu; Narikazu Boku; Shuichi Hironaka; Kiyomi Mera; Manabu Muto; Takashi Ogino; Shigeaki Yoshida
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

9.  Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus.

Authors:  Louis Fenkell; Inna Kaminsky; Stephen Breen; Sophie Huang; Monique Van Prooijen; Jolie Ringash
Journal:  Radiother Oncol       Date:  2008-09-12       Impact factor: 6.280

10.  Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.

Authors:  Steven H Lin; Lu Wang; Bevan Myles; Peter F Thall; Wayne L Hofstetter; Stephen G Swisher; Jaffer A Ajani; James D Cox; Ritsuko Komaki; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-03       Impact factor: 7.038

View more
  3 in total

1.  A hybrid phase I-II/III clinical trial design allowing dose re-optimization in phase III.

Authors:  Andrew G Chapple; Peter F Thall
Journal:  Biometrics       Date:  2019-04-03       Impact factor: 2.571

2.  Bayesian Semiparametric Joint Regression Analysis of Recurrent Adverse Events and Survival in Esophageal Cancer Patients.

Authors:  Juhee Lee; Peter F Thall; Steven H Lin
Journal:  Ann Appl Stat       Date:  2019-04-10       Impact factor: 2.083

3.  Semi-competing risk model to predict perioperative and oncologic outcomes after radical cystectomy.

Authors:  Taylor Peak; Andrew Chapple; Grayson Coon; Ashok Hemal
Journal:  Ther Adv Urol       Date:  2018-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.